https://www.businesswire.com/news/home/20250326223440/en/Alcon-Acquires-Majority-Interest-in-Aurion-Biotech-Inc.-to-Advance-Innovative-Cell-Therapy-for-Corneal-Endothelial-Disease
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
majority interestalconacquiresaurionbiotech